Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
63.54
-0.30 (-0.47%)
Oct 27, 2025, 4:00 PM EDT - Market closed
Henry Schein Market Cap
Henry Schein has a market cap or net worth of $7.71 billion as of October 28, 2025. Its market cap has decreased by -13.17% in one year.
Market Cap
7.71B
Enterprise Value
10.92B
1-Year Change
-13.17%
Ranking
Category
Stock Price
$63.54
Market Cap Chart
Since December 1, 1998, Henry Schein's market cap has increased from $1.43B to $7.71B, an increase of 439.74%. That is a compound annual growth rate of 6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 7.71B | -10.69% |
| Dec 31, 2024 | 8.63B | -12.30% |
| Dec 29, 2023 | 9.84B | -9.13% |
| Dec 30, 2022 | 10.83B | 0.70% |
| Dec 31, 2021 | 10.75B | 12.63% |
| Dec 31, 2020 | 9.55B | -2.50% |
| Dec 31, 2019 | 9.79B | -18.20% |
| Dec 31, 2018 | 11.97B | 9.13% |
| Dec 29, 2017 | 10.97B | -10.18% |
| Dec 30, 2016 | 12.21B | -6.91% |
| Dec 31, 2015 | 13.12B | 14.41% |
| Dec 31, 2014 | 11.47B | 16.88% |
| Dec 31, 2013 | 9.81B | 38.62% |
| Dec 31, 2012 | 7.08B | 21.55% |
| Dec 30, 2011 | 5.82B | 2.78% |
| Dec 31, 2010 | 5.66B | 19.02% |
| Dec 31, 2009 | 4.76B | 45.17% |
| Dec 31, 2008 | 3.28B | -40.37% |
| Dec 31, 2007 | 5.50B | 26.72% |
| Dec 29, 2006 | 4.34B | 14.05% |
| Dec 30, 2005 | 3.80B | 26.25% |
| Dec 31, 2004 | 3.01B | 2.15% |
| Dec 31, 2003 | 2.95B | 48.97% |
| Dec 31, 2002 | 1.98B | 25.28% |
| Dec 31, 2001 | 1.58B | 9.84% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |